Table 3. Functional clustering of differentially expressed genes of hMSC-OP, hMSC-old and hMSC-senescent when compared to hMSC-C.
Symbol | Gene name | hMSC-OP | hMSC-old | hMSC-senescent | Reference | ||||||
(1) Osteoblastogenesis | |||||||||||
positive | |||||||||||
PTH1R | parathyroid hormone 1 receptor | ↑ | [74] | ||||||||
IBSP | integrin-binding sialoprotein | ↑ | [75] | ||||||||
INHA | inhibin, alpha | ↑ | [76] | ||||||||
IGFBP2 | insulin-like growth factor binding protein 2 | ↑ | [77] | ||||||||
IGF2 | insulin-like growth factor 2 | ↑ | ↓ | [77] | |||||||
VEGFB | vascular endothelial growth factor B | ↑ | ↓ | [78] | |||||||
VEGFA | vascular endothelial growth factor A | ↑ | ↓ | ↓ | [78] | ||||||
FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | ↑ | ↓ | [79] | |||||||
COL1A1 | collagen, type I, alpha 1 | ↓ | [75] | ||||||||
RUNX2 | runt-related transcription factor 2 | ↓ | [75] | ||||||||
ANKH* | ankylosis, progressive homolog | ↓ | ↓ | [80] | |||||||
SMAD3B | SMAD family member 3 | ↓ | [81] | ||||||||
SPP1 | secreted phosphoprotein 1 | ↓ | [75] | ||||||||
EFNB2 | ephrin-B2 | ↓ | [82] | ||||||||
ALPL | alkaline phosphatase, liver/bone/kidney | ↓ | [80] | ||||||||
CYP2R1 | cytochrome P450, family 2, subfamily R, polypeptide 1 | ↓ | [80], [83] | ||||||||
FOXC1 | forkhead box C1 | ↑ | ↓ | [84] | |||||||
IL6ST | interleukin 6 signal transducer (Oncostatin M receptor) | ↓ | ↑ | [85] | |||||||
PDGFA | platelet-derived growth factor alpha polypeptide | ↑ | [11] | ||||||||
VDR | vitamin D receptor | ↑ | [80] | ||||||||
FGFR2* | fibroblast growth factor receptor 2 | ↑ | ↓ | [86] | |||||||
BMP6B | bone morphogenetic protein 6 | ↑ | [11] | ||||||||
ROR1W | receptor tyrosine kinase-like orphan receptor 1 | ↓ | ↑ | [87] | |||||||
ANKRD6W | ankyrin repeat domain 6 | ↑ | [16], [18] | ||||||||
negative | |||||||||||
TGFB1 | transforming growth factor, beta 1 | ↑ | ↓ | [88] | |||||||
MAB21L2B | mab-21-like 2 | ↑ | ↑ | [15] | |||||||
FST | follistatin | ↑ | ↑ | [89], [90] | |||||||
FSTL3 | follistatin-like 3 | ↑ | [91] | ||||||||
KREMEN1W | kringle containing transmembrane protein 1 | ↑ | [38] | ||||||||
SOSTW B | sclerostin | ↑ | [23] | ||||||||
FGFR1 | fibroblast growth factor receptor 1 | ↑ | [92] | ||||||||
IGFBP5 | insulin-like growth factor binding protein 5 | ↑ | ↑ | [11] | |||||||
IGFBP4 | insulin-like growth factor binding protein 4 | ↓ | [11] | ||||||||
EGFR | epidermal growth factor receptor | ↓ | [93] | ||||||||
GREM2B | gremlin 2, cysteine knot superfamily, homolog | ↓ | ↓ | [94] | |||||||
NOGB | noggin | ↑ | [11] | ||||||||
CTNNB1W | catenin, beta 1 | ↑ | [17], [18] | ||||||||
SFRP4W | secreted frizzled-related protein 4 | ↑ | [95] | ||||||||
WNT2W | wingless-type MMTV integration site family, member 2 | ↑ | [17], [18] | ||||||||
WNT3W | wingless-type MMTV integration site family, member 3 | ↑ | [17], [18] | ||||||||
(2) Osteoclastogenesis | |||||||||||
positive | |||||||||||
PTH1R | parathyroid hormone 1 receptor | ↑ | [25] | ||||||||
CSF1 | colony stimulating factor 1 | ↑ | [4] | ||||||||
PTGS2 | prostaglandin-endoperoxide synthase 2 | ↑ | ↓ | [96] | |||||||
IGF2 | insulin-like growth factor 2 | ↑ | ↓ | [97] | |||||||
TNFSF11 | tumor necrosis factor superfamily, member 11 | ↓ | [98] | ||||||||
SPP1 | secreted phosphoprotein 1 | ↓ | [99] | ||||||||
IL7 | interleukin 7 | ↓ | [100] | ||||||||
THBS1 | thrombospondin 1 | ↑ | [101] | ||||||||
IL1A* | interleukin 1, alpha | ↓ | ↑ | [67] | |||||||
TNFSF10 | tumor necrosis factor superfamily, member 10 | ↓ | ↓ | [102] | |||||||
TGFB2 | transforming growth factor, beta 2 | ↓ | ↓ | [103] | |||||||
VEGFA | vascular endothelial growth factor A | ↑ | ↓ | ↓ | [46] | ||||||
VEGFB | vascular endothelial growth factor B | ↑ | ↓ | [46] | |||||||
TGFB1 | transforming growth factor, beta 1 | ↑ | ↓ | [47] | |||||||
RUNX2 | runt-related transcription factor 2 | ↓ | [104] | ||||||||
negative | |||||||||||
TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | ↑ | [98] | ||||||||
FSTL3 | follistatin-like 3 | ↑ | [105] | ||||||||
(3) Proliferation | |||||||||||
positive | |||||||||||
HMMR | hyaluronan-mediated motility receptor | ↓ | ↓ | [49] | |||||||
HELLS | helicase, lymphoid-specific | ↓ | [106] | ||||||||
PTN | pleiotrophin | ↓ | [107] | ||||||||
SOD2 | superoxide dismutase 2, mitochondrial | ↓ | ↑ | [108] | |||||||
CCNB2 | cyclin B2 | ↓ | [109] | ||||||||
CDC2 | cell division cycle 2, G1 to S and G2 to M | ↓ | ↓ | [109] | |||||||
CCNA2 | cyclin A2 | ↓ | ↓ | ↓ | [109] | ||||||
CCNE2 | cyclin E2 | ↓ | ↓ | ↓ | [109] | ||||||
CCNF | cyclin F | ↓ | [110] | ||||||||
CCND1 | cyclin D1 | ↑ | [109] | ||||||||
CCND2 | cyclin D2 | ↑ | [109] | ||||||||
CDC25A | cell division cycle 25 homolog A | ↓ | [111] | ||||||||
CDC25B | cell division cycle 25 homolog B | ↓ | [112] | ||||||||
CDC25C | cell division cycle 25 homolog C | ↓ | [113] | ||||||||
CDK2 | cyclin-dependent kinase 2 | ↓ | [109] | ||||||||
negative | |||||||||||
PSG1 | pregnancy specific beta-1-glycoprotein 1 | ↑ | [114] | ||||||||
PSG2 | pregnancy specific beta-1-glycoprotein 2 | ↑ | [114] | ||||||||
PSG3 | pregnancy specific beta-1-glycoprotein 3 | ↓ | ↑ | [114] | |||||||
PSG4 | pregnancy specific beta-1-glycoprotein 4 | ↑ | [114] | ||||||||
PSG6 | pregnancy specific beta-1-glycoprotein 6 | ↑ | [114] | ||||||||
PSG7 | pregnancy specific beta-1-glycoprotein 7 | ↑ | [114] | ||||||||
ARHGAP29 | Rho GTPase activating protein 29 | ↓ | ↑ | [107] | |||||||
CDKN2A | cyclin-dependent kinase inhibitor 2A | ↑ | [107] | ||||||||
CDKN1A | cyclin-dependent kinase inhibitor 1A | ↑ | [50] | ||||||||
(4) DNA-repair | |||||||||||
positive | |||||||||||
POLD1 | polymerase (DNA directed), delta 1, catalytic subunit 125kDa | ↓ | [115] | ||||||||
POLE2 | polymerase (DNA directed), epsilon 2 (p59 subunit) | ↓ | ↓ | [115] | |||||||
POLQ | polymerase (DNA directed), theta | ↓ | [115] | ||||||||
POLH | polymerase (DNA directed), eta | ↓ | [115] | ||||||||
POLK | polymerase (DNA directed) kappa | ↓ | [115] | ||||||||
MRE11A | MRE11 meiotic recombination 11 homolog A | ↓ | [116] | ||||||||
PARP3 | poly (ADP-ribose) polymerase family, member 3 | ↓ | [117] | ||||||||
RAD50 | RAD50 homolog | ↓ | [116] | ||||||||
RAD51 | RAD51 homolog | ↓ | [116] | ||||||||
RAD51AP1 | RAD51 associated protein 1 | ↓ | ↓ | [118] | |||||||
TOP2A | topoisomerase (DNA) II alpha 170 kDa | ↓ | ↓ | [119] | |||||||
EXO1 | exonuclease 1 | ↓ | [116] | ||||||||
CHEK1 | CHK1 checkpoint homolog | ↓ | [120] | ||||||||
HMGB2 | high-mobility group box 2 | ↓ | [121] |
arrows pointing downward = at least 2fold reduced expression in comparison to hMSC-C; arrows pointing upward = at least 2fold enhanced expression in comparison to hMSC-C;
= gene associated with WNT signaling;
= gene associated with BMP signaling;
= probesets that refer to the gene are not identical in the indicated comparisons.